|本期目录/Table of Contents|

[1]李思锐,胥俊越.血清ANGPTL4、THBS2与2型糖尿病合并非酒精性脂肪性肝病患者糖代谢及肝功能的相关性[J].国际消化病杂志,2024,06:393-397，414.
　LI Sirui,XU Junyue.Correlation between serum ANGPTL4, THBS2, glucose metabolism, and liver function in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease[J].International Journal of Digestive Disease,2024,06:393-397，414.
点击复制

血清ANGPTL4、THBS2与2型糖尿病合并非酒精性脂肪性肝病患者糖代谢及肝功能的相关性(PDF)

《国际消化病杂志》[ISSN:1673-534X/CN:31-1953/R]

期数:
2024年06期
页码:
393-397，414
栏目:
论著
出版日期:
2024-12-20

文章信息/Info

Title:
Correlation between serum ANGPTL4, THBS2, glucose metabolism, and liver function in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
作者:
李思锐; 胥俊越
100073 北京电力医院内分泌科（李思锐），检验科（胥俊越）
Author(s):
LI Sirui; XU Junyue
LI Sirui. Department of Endocrinology, Beijing Electric Power Hospital, Beijing 100073, China; XU Junyue. Department of Laboratory, Beijing Electric Power Hospital, Beijing 100073, China
关键词:
血管生成素样蛋白4 ; 血小板反应蛋白2 ; 2型糖尿病; 非酒精性脂肪性肝病; 肝功能
Keywords:
Angiopoietin-like protein 4;  Thrombospondin-2;  Type 2 diabetes mellitus; Nonalcoholic fatty liver disease;  Liver function
分类号:
-
DOI:
10.3969/j.issn.1673-534X.2024.06.009
文献标识码:
-
摘要:
目的探究血清血管生成素样蛋白4（ANGPTL4）、血小板反应蛋白2（THBS2）与2型糖尿病（T2DM）合并非酒精性脂肪性肝病（NAFLD）患者糖代谢及肝功能的相关性。方法选择2021年4月至2023年4月北京电力医院收治的95例T2DM合并NAFLD患者设为研究组，另选择同期该院收治的95例单纯性T2DM患者设为对照组。采用ELISA法检测2组的血清ANGPTL4、THBS2表达水平。采用Pearson相关分析探讨血清ANGPTL4、THBS2与T2DM合并NAFLD患者糖代谢和肝功能的相关性。采用多因素logistic回归分析探讨T2DM合并NAFLD的影响因素。采用ROC曲线分析血清ANGPTL4、THBS2表达水平诊断T2DM合并NAFLD的价值。结果与对照组相比，研究组的胰岛素抵抗指数（Homa-IR）和三酰甘油（TG）、ALT、ANGPTL4及THBS2表达水平均显著升高（P均＜0.05），高密度脂蛋白胆固醇（HDL-C）水平显著降低（P＜0.05）。Pearson相关分析结果显示，T2DM合并NAFLD患者的血清ANGPTL4与Homa-IR、ALT均呈正相关（P均＜0.05），血清THBS2与HOMA-IR、ALT也均呈正相关（P均＜0.05）。多因素logistic回归分析结果显示，ANGPTL4、THBS2、TG、ALT、Homa-IR均是T2DM患者合并NAFLD的危险因素（P均＜0.05），而HDL-C则是T2DM患者合并NAFLD的保护因素（P＜0.05）。血清ANGPTL4、THBS2单独及联合检测诊断T2DM患者合并NAFLD的ROC曲线下面积（AUC）分别为0.778、0.807和0.897，2项联合检测的诊断价值分别高于单独检测（Z2项联合-ANGPTL4＝4.023，Z2项联合-THBS2＝3.957，P均＜0.001）。结论T2DM合并NAFLD患者的血清ANGPTL4、THBS2表达水平均升高，这2项指标与T2DM合并NAFLD患者的糖代谢和肝功能均密切相关。
Abstract:
Objective? This paper aims to explore the relationship between serum angiopoietin-like protein 4 (ANGPTL4), thrombospondin-2 (THBS2), glucose metabolism, and liver function in patients with type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD). Methods? A total of 95 patients with T2DM and NAFLD, admitted to Beijing Electric Power Hospital between April 2021 and April 2023, were selected as the research group, and another 95 patients with simple T2DM, admitted to the hospital during the same period, were selected as the control group. ELISA was used to detect the expression levels of serum ANGPTL4 and THBS2 in both groups. Pearson correlation analysis was performed to explore the relationship between serum ANGPTL4, THBS2, glucose metabolism, and liver function in T2DM patients with NAFLD. Multivariate logistic regression analysis was used to explore the influencing factors of T2DM patients with NAFLD. The ROC curve was used to analyze the diagnostic value of serum ANGPTL4 and THBS2 in T2DM with NAFLD. Results? Compared with the control group, the research group has significantly higher levels of HOMA-IR, triglycerides (TG), ALT, ANGPTL4, and THBS2 (P＜0.05), while the high-density lipoprotein cholesterol (HDL-C) level is significantly lower (P＜0.05). Pearson correlation analysis reveals that serum ANGPTL4 is positively correlated with HOMA-IR and ALT in T2DM patients with NAFLD (P＜0.05). Similarly, serum THBS2 is positively correlated with HOMA-IR and ALT level (P＜0.05). Multivariate logistic regression analysis shows that ANGPTL4, THBS2, TG, ALT, and HOMA-IR are risk factors for T2DM patients with NAFLD (P＜0.05), while HDL-C is a protective factor for T2DM patients with NAFLD (P＜0.05). The ROC curve analysis shows that the area under the curve (AUC) for the diagnosis of T2DM with NAFLD using serum ANGPTL4 and THBS2 alone and in combination are 0.778, 0.807, and 0.897, respectively. The combination of ANGPTL4 and THBS2 provides a higher diagnostic value than that of the detection of serum ANGPTL4 and THBS2 alone (Zcombination-ANGPTL4＝4.023, Zcombination-THBS2＝3.957, P＜0.001). Conclusions? The expression levels of serum ANGPTL4 and THBS2 are both elevated in patients with T2DM and NAFLD. These two biomarkers are closely related to the glucose metabolism and liver function in patients with T2DM combined with NAFLD.

参考文献/References

1Zupa MF, Codario RA, Smith KJ. Cost-effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes[J]. J Comp Eff Res, 2021, 10(15): 1133-1141.
2Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98.
3Li F, Wu X, Zhang Y, et al. Plasma miR-513a-5p as a potential biomarker for diagnosis of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients[J]. Clin Lab, 2020, 66(5).
4 杨燕, 姚艺璇, 洪秀韬, 等. 应用胰岛素抵抗替代指标评估2型糖尿病患者非酒精性脂肪肝及进展性肝纤维化的价值[J]. 中华内分泌代谢杂志, 2021, 37(4): 281-287.
5 周林, 王永海, 宋晓锋, 等. 2型糖尿病合并非酒精性脂肪肝患者血清non-HDL、RBP、RBP-4及脂联素水平观察[J]. 临床和实验医学杂志, 2023, 22(8): 813-817.
6Li JJ, Zhang P, Fan B, et al. The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: preliminary data[J]. Rev Assoc Med Bras (1992), 2019, 65(1): 33-37.
7Fernández-Hernando C, Suárez Y. ANGPTL4: a multifunctional protein involved in metabolism and vascular homeostasis[J]. Curr Opin Hematol, 2020, 27(3): 206-213.
8 杨龙艳, 王岩, 许月超, 等. 血管生成素样蛋白4在非酒精性脂肪肝诊断中的应用效果分析[J]. 首都医科大学学报, 2020, 41(1):31-34.
9 范冲冲, 叶圣昌, 陈贤真, 等. 血清THBS2在非小细胞肺癌中的表达及临床意义[J]. 中国实验诊断学, 2020, 24(7): 1061-1064.
10 Nan P, Dong X, Bai X, et al. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK pathway[J]. Cancer Lett, 2022, 528: 59-75.
11 Kozumi K, Kodama T, Murai H, et al. Transcriptomics identify thrombospondin-2 as a biomarker for NASH and advanced liver fibrosis[J]. Hepatology, 2021, 74(5): 2452-2466.
12 中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和糖尿病外科医师委员会, 王勇, 等. 中国肥胖及2型糖尿病外科治疗指南（2019版）[J]. 中国实用外科杂志, 2019, 39(4): 301-306.
13 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会, 范建高, 等. 非酒精性脂肪性肝病防治指南（2018更新版）[J]. 传染病信息, 2018, 31(5): 393-402, 420.
14 靳睿, 王晓晓, 刘峰, 等. 非酒精性脂肪性肝病的药物治疗进展[J].临床肝胆病杂志, 2022, 38(7): 1634-1640.
15 Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease[J]. Lancet, 2021, 397(10290): 2212-2224.
16 Cariou B, Byrne CD, Loomba R, et al. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review[J]. Diabetes Obes Metab, 2021, 23(5): 1069-1083.
17 Aryal B, Price NL, Suarez Y, et al. ANGPTL4 in metabolic and cardiovascular disease[J]. Trends Mol Med, 2019, 25(8): 723-734.
18 陈晶晶, 方爱英. 血清ANGPTL4、CTRP12水平与老年2型糖尿病合并非酒精性脂肪肝病的相关性[J]. 川北医学院学报, 2023, 38(7): 923-926.
19 封令娟, 金兴权. 糖尿病肾病患者血清CTRP3、ANGPTL4和ATX水平变化及临床意义[J]. 检验医学与临床, 2022, 19(9):1196-1200.
20 Yang H, Sun B, Fan L, et al. Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma[J]. Theranostics, 2022, 12(7): 3104-3130.
21 张青, 王翔, 鞠强, 等. 糖尿病肾病肾关键基因的分析鉴定[J]. 精准医学杂志, 2021, 36(3): 246-250.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2024-12-20